Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 USD | +6.49% | +0.15% | +1.08% |
Mar. 27 | UBS Trims Terns Pharmaceuticals Price Target to $18 From $19, Maintains Buy Rating | MT |
Mar. 22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.08% | 398M | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |
- Stock
- Equities
- Stock Terns Pharmaceuticals, Inc. - Nasdaq
- News Terns Pharmaceuticals, Inc.
- Terns Pharmaceuticals' : Q2 Loss Narrows, Operating Expenses Increase; Shares Climb